<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="jps" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">jps</book-part-id>
      <title-group>
        <title>Juvenile Polyposis Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Larsen Haidle</surname>
            <given-names>Joy</given-names>
          </name>
          <degrees>MS, CGC</degrees>
          <aff>Humphrey Cancer Center<break/>North Memorial Hospital<break/>Robbinsdale, Minnesota</aff>
          <email>joy.larsen.haidle@northmemorial.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Howe</surname>
            <given-names>James R</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Surgery<break/>University of Iowa Hospitals and Clinics<break/>Iowa City, Iowa</aff>
          <email>james-howe@uiowa.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>13</day>
          <month>5</month>
          <year>2003</year>
        </date>
        <date date-type="updated">
          <day>9</day>
          <month>3</month>
          <year>2017</year>
        </date>
        <date date-type="revised">
          <day>3</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="jh" document-type="chapter">Juvenile Hereditary Hemochromatosis</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="mdel17q21_31" document-type="chapter">
<italic toggle="yes">KANSL1</italic>-Related Intellectual Disability Syndrome</related-object>
      <abstract id="jps.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Juvenile polyposis syndrome (JPS) is characterized by predisposition to hamartomatous polyps in the gastrointestinal (GI) tract, specifically in the stomach, small intestine, colon, and rectum. The term "juvenile" refers to the type of polyp rather than to the age of onset of polyps. Most individuals with JPS have some polyps by age 20 years; some may have only four or five polyps over their lifetime, whereas others in the same family may have more than 100. If the polyps are left untreated, they may cause bleeding and anemia. Most juvenile polyps are benign; however, malignant transformation can occur. Risk for GI cancers in families with JPS ranges from 9% to 50%. Most of this increased risk is attributed to colon cancer, but cancers of the stomach, upper GI tract, and pancreas have also been reported. A combined syndrome of JPS and hereditary hemorrhagic telangiectasia (JPS/HHT) is present in most individuals with an <italic toggle="yes">SMAD4</italic> pathogenic variant.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of JPS is established in a proband with any of the following: more than five juvenile polyps of the colorectum; multiple juvenile polyps throughout the GI tract; any number of juvenile polyps and a family history of juvenile polyposis. Identification of a heterozygous pathogenic variant in <italic toggle="yes">SMAD4</italic> or <italic toggle="yes">BMPR1A</italic> confirms the diagnosis if clinical features are inconclusive.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Routine colonoscopy with endoscopic polypectomy to reduce the risk of cancer, bleeding, and intestinal obstruction. When a large number of polyps are present, removal of all or part of the colon or stomach may be necessary. Treatment as needed for manifestations of HHT.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Cancer prevention/risk reduction through cancer screening.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Anemia may be improved by polypectomy or surgery.</p>
          <p><italic toggle="yes">Surveillance</italic>: For individuals following surgical resection: endoscopic evaluation of the rectum and pouch is required. For individuals at risk: monitoring for rectal bleeding and/or anemia, abdominal pain, constipation, and diarrhea; screening by complete blood count (CBC), colonoscopy, and upper endoscopy starting in the mid-teens (age 15 years) or earlier if symptoms occur. In families with JPS/HHT syndrome and/or a known <italic toggle="yes">SMAD4</italic> pathogenic variant: it may be appropriate to follow the HHT surveillance guidelines.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk</italic>: When the family-specific pathogenic variant is known, it is appropriate to perform molecular genetic testing on at-risk family members in the first to second decade of life to identify those who will benefit from early surveillance and intervention.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>JPS is inherited in an autosomal dominant manner. Approximately 33% of individuals with JPS have an affected parent; approximately 67% of probands with JPS have no previous history of polyps in the family and may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. Each child of an affected individual has a 50% chance of inheriting the pathogenic variant and developing JPS. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="jps.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="jps.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_jps.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Juvenile Polyposis Syndrome: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_jps.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Juvenile polyposis syndrome (JPS)</p>
                    </list-item>
                    <list-item>
                      <p>Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JPS/HHT syndrome)</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="jps.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="jps.Diagnosis">
        <title>Diagnosis</title>
        <sec id="jps.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Juvenile polyposis syndrome (JPS) <bold>should be suspected</bold> in a proband with the following clinical and histopathology features.</p>
          <p>
            <bold>Clinical features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Anemia, rectal bleeding, or prolapse of rectal polyp</p>
            </list-item>
            <list-item>
              <p>More than one juvenile polyp</p>
            </list-item>
            <list-item>
              <p>One or more juvenile polyps and a family history of JPS</p>
            </list-item>
          </list>
          <p>Note: "Juvenile" refers to the polyp histopathology not the age of onset of polyps.</p>
          <p><bold>Histopathology features.</bold> Juvenile polyps are hamartomas that develop from an abnormal collection of tissue elements normally present at this site. Juvenile polyps show a normal epithelium with a dense stroma, an inflammatory infiltrate, and a smooth surface with dilated, mucus-filled cystic glands in the lamina propria. Muscle fibers and the proliferative characteristics of adenomas are typically not seen in juvenile polyps.</p>
          <p>Note: Variability in histopathology has been reported in polyps associated with JPS/HHT syndrome (see <xref ref-type="sec" rid="jps.Clinical_Characteristics">Clinical Characteristics</xref>) [<xref ref-type="bibr" rid="jps.REF.aretz.2007.702">Aretz et al 2007</xref>].</p>
        </sec>
        <sec id="jps.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of JPS <bold>is established</bold> in a proband with <bold>any one</bold> of the following clinical features:</p>
          <list list-type="bullet">
            <list-item>
              <p>More than five juvenile polyps of the colon or rectum</p>
            </list-item>
            <list-item>
              <p>Multiple juvenile polyps of the upper and lower GI tract</p>
            </list-item>
            <list-item>
              <p>Any number of juvenile polyps and a family history of juvenile polyposis</p>
            </list-item>
            <list-item>
              <p>Identification of a heterozygous pathogenic variant in one of the genes listed in <xref ref-type="table" rid="jps.T.molecular_genetic_testing_used_in">Table 1</xref></p>
            </list-item>
          </list>
          <p>Molecular genetic testing approaches can include <bold><italic toggle="yes">BMPR1A</italic> and <italic toggle="yes">SMAD4</italic> concurrent testing</bold>, <bold>serial single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>:</p>
          <p><bold><italic toggle="yes">BMPR1A</italic> and <italic toggle="yes">SMAD4</italic> concurrent testing</bold> can be considered in individuals with clinical features suggestive of JPS. Sequence analysis and gene-targeted deletion/duplication analysis of <italic toggle="yes">BMPR1A</italic> and <italic toggle="yes">SMAD4</italic> is performed first. If no pathogenic variant is found reflex to a multi-gene panel that includes <italic toggle="yes">PTEN</italic> and other genes of interest (see <xref ref-type="sec" rid="jps.Differential_Diagnosis">Differential Diagnosis</xref>, <xref ref-type="table" rid="jps.T.disorders_to_consider_in_the_diffe">Table 3</xref> and <xref ref-type="table" rid="jps.T.disorders_to_consider_in_the_diffe_1">Table 4</xref>).</p>
          <p><bold>Serial single-gene testing</bold> can be considered in individuals with clinical features suggestive of JPS/HHT (see <xref ref-type="table" rid="jps.T.clinical_features_of_hereditary_he">Table 2</xref> and <related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter">hereditary hemorrhagic telangiectasia</related-object>).</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>Sequence analysis and deletion/duplication analysis of <italic toggle="yes">SMAD4</italic> is performed first.</p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>Sequence analysis and deletion/duplication analysis of <italic toggle="yes">BMPR1A</italic> should be considered next if no <italic toggle="yes">SMAD4</italic> pathogenic variant is identified.</p>
            </list-item>
            <list-item>
              <label>3</label>
              <p>Consider molecular genetic testing of additional HHT-related genes if an <italic toggle="yes">SMAD4</italic> or <italic toggle="yes">BMPR1A</italic> pathogenic variant has not been identified.</p>
            </list-item>
          </list>
          <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">BMPR1A</italic>, <italic toggle="yes">SMAD4</italic>, and other genes of interest (see <xref ref-type="sec" rid="jps.Differential_Diagnosis">Differential Diagnosis</xref>) &#x02013; in particular <italic toggle="yes">PTEN</italic> (see *) &#x02013; may be considered in individuals with JPS. Note: (1) The genes included and the sensitivity of multi-gene panels vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests. (4) Understanding the limitations of the panel is critical for interpreting a negative test result and determining if additional testing is required. It is important to ensure that the panel provides the best coverage for the genes with the highest clinical suspicion and includes analysis of the promoter regions.</p>
          <list list-type="bullet">
            <list-item>
              <p>Deletions of 10q22-q23 detectable by <bold>chromosomal microarray analysis</bold> including either <italic toggle="yes">BMPR1A</italic> or both <italic toggle="yes">BMPR1A</italic> and <italic toggle="yes">PTEN</italic> may be associated with additional clinical features with or without juvenile polyposis or with severe early-onset JPS [<xref ref-type="bibr" rid="jps.REF.delnatte.2006.1066">Delnatte et al 2006</xref>, <xref ref-type="bibr" rid="jps.REF.salviati.2006.593">Salviati et al 2006</xref>, <xref ref-type="bibr" rid="jps.REF.van_hattem.2008.623">van Hattem et al 2008</xref>, <xref ref-type="bibr" rid="jps.REF.calvacerqueira.2009.79">Calva-Cerqueira et al 2009</xref>, <xref ref-type="bibr" rid="jps.REF.breckpot.2012.12">Breckpot et al 2012</xref>]. Hamartomatous polyposis and 10q22-q23 deletions have been reviewed by <xref ref-type="bibr" rid="jps.REF.dahdaleh.2012.110">Dahdaleh et al [2012]</xref>.</p>
            </list-item>
          </list>
          <p>* If no pathogenic variant is found, molecular genetic testing of <italic toggle="yes">PTEN</italic> is appropriate to determine if the individual has <related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic> hamartoma tumor syndrome</related-object> rather than JPS (see also <xref ref-type="sec" rid="jps.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</xref>).</p>
          <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
          <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
          <table-wrap id="jps.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Juvenile Polyposis Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_2">Proportion of Juvenile Polyposis Syndrome Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>3</sup></th>
                  <th headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">BMPR1A</italic>
                  </td>
                  <td headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">28%&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jps.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">69%-85%&#x000a0;<sup>5,&#x000a0;6</sup></td>
                  <td headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jps.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">15%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SMAD4</italic>
                  </td>
                  <td headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">27%&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jps.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">83%&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jps.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">17%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">45%</td>
                  <td headers="hd_h_jps.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jps.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_jps.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" colspan="2" align="left" rowspan="1">NA</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="jps.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="jps" object-id="jps.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="jps.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="jps.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="jps.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="jps.TF.1.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="jps.TF.1.5">
                <label>5. </label>
                <p><xref ref-type="bibr" rid="jps.REF.aretz.2007.702">Aretz et al [2007]</xref>, <xref ref-type="bibr" rid="jps.REF.van_hattem.2008.623">van Hattem et al [2008]</xref>, <xref ref-type="bibr" rid="jps.REF.calvacerqueira.2009.79">Calva-Cerqueira et al [2009]</xref>, <xref ref-type="bibr" rid="jps.REF.latchford.2012.1038">Latchford et al [2012]</xref></p>
              </fn>
              <fn id="jps.TF.1.6">
                <label>6. </label>
                <p>Sequence analysis of the <italic toggle="yes">BMPR1A</italic> promotor region identified a pathogenic variant in 6/65 individuals with JPS who did not have a <italic toggle="yes">BMPR1A</italic> or <italic toggle="yes">SMAD4</italic> pathogenic variant identified on sequencing of the coding regions or deletion/duplication testing [<xref ref-type="bibr" rid="jps.REF.calvacerqueira.2010.4654">Calva-Cerqueira et al 2010</xref>]. Sequence analysis that includes the promoter region increases the proportion of pathogenic variants detected by sequencing.</p>
              </fn>
              <fn id="jps.TF.1.7">
                <label>7. </label>
                <p>Two individuals with early-onset JPS have been found to have <italic toggle="yes">ENG</italic> pathogenic variants. Neither had clinical symptoms of <related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter">hereditary hemorrhagic telangiectasia</related-object> (HHT), which is known to be associated with <italic toggle="yes">ENG</italic> pathogenic variants; however, neither had yet reached the age at which symptoms of HHT commonly manifest [<xref ref-type="bibr" rid="jps.REF.sweet.2005.2465">Sweet et al 2005</xref>, <xref ref-type="bibr" rid="jps.REF.howe.2007.91">Howe et al 2007</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="jps.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="jps.Clinical_Description">
          <title>Clinical Description</title>
          <p><bold>Juvenile polyposis syndrome (JPS)</bold> is characterized by predisposition to hamartomatous polyps in the gastrointestinal (GI) tract, specifically in the stomach, small intestine, colon, and rectum. &#x0201c;Generalized juvenile polyposis&#x0201d; refers to polyps of the upper and lower GI tract. &#x0201c;Juvenile polyposis coli&#x0201d; refers to polyps of the colon only.</p>
          <p>The polyps vary in size and shape: some are flat (sessile), whereas others have a stalk (pedunculated). The number of polyps in individuals with JPS varies. Some individuals may have only four or five polyps over their lifetime; others in the same family may have more than 100.</p>
          <p>Bleeding may result from sloughing of the polyp or its surface epithelium with the passage of stool. If the polyps are left untreated, they may cause bleeding and anemia.</p>
          <p>Juvenile polyps develop from infancy through adulthood. Most individuals with JPS have some polyps by age 20 years.</p>
          <p>In juvenile polyposis of infancy, polyps develop within the first few years of life and are accompanied by hypoproteinemia, protein-losing enteropathy, diarrhea, anemia, anasarca, and failure to thrive.</p>
          <p><bold>Cancer risks associated with JPS.</bold> Most juvenile polyps are benign; however, malignant transformation can occur. Lifetime estimates of developing GI cancers in families with JPS range from 9% to 50% [<xref ref-type="bibr" rid="jps.REF.howe.1998b.1086">Howe et al 1998b</xref>, <xref ref-type="bibr" rid="jps.REF.brosens.2007.965">Brosens et al 2007</xref>, <xref ref-type="bibr" rid="jps.REF.latchford.2012.1038">Latchford et al 2012</xref>]; of individuals treated surgically and followed with surveillance, four of 27 individuals with <italic toggle="yes">SMAD4</italic> pathogenic variants and 0 of 8 individuals with <italic toggle="yes">BMPR1A</italic> pathogenic variants developed cancer [<xref ref-type="bibr" rid="jps.REF.aytac.2015.114">Aytac et al 2015</xref>]. Most of the increased risk is attributed to colon cancer; cancers of the stomach, upper GI tract, and pancreas have also been reported:</p>
          <list list-type="bullet">
            <list-item>
              <p>The incidence of colorectal cancer is 17%-22% by age 35 years and approaches 68% by age 60 years. The median age at diagnosis is 42 years.</p>
            </list-item>
            <list-item>
              <p>The incidence of gastric cancer is 21% in those with gastric polyps.</p>
            </list-item>
            <list-item>
              <p>The relative risk for colorectal cancer was 34.0 in individuals with JPS. The mean age of diagnosis of colorectal cancer was 43.9 years, with a cumulative lifetime risk of 38.7% [<xref ref-type="bibr" rid="jps.REF.brosens.2007.965">Brosens et al 2007</xref>].</p>
            </list-item>
          </list>
          <p>In one large family with a germline <italic toggle="yes">SMAD4</italic> pathogenic variant, the risk for colon cancer was approximately 40%, and the risk for upper GI cancers was 20% [<xref ref-type="bibr" rid="jps.REF.howe.1998b.1086">Howe et al 1998b</xref>]. However, these cancer rates may change over time with the implementation of screening of young at-risk individuals and the removal of polyps before cancer develops.</p>
          <p><bold>Juvenile polyposis syndrome/hereditary hemorrhagic telangiectasia (JPS/HHT syndrome).</bold> Individuals with JPS/HHT syndrome have variable findings of juvenile polyposis and <related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter">hereditary hemorrhagic telangiectasia</related-object> (epistaxis, telangiectases, arteriovenous malformations, and digital clubbing). Most individuals with JPS who have an <italic toggle="yes">SMAD4</italic> germline pathogenic variant have one or more clinical features of HHT (see <xref ref-type="table" rid="jps.T.clinical_features_of_hereditary_he">Table 2</xref>) [<xref ref-type="bibr" rid="jps.REF.o_malley.2012.886">O&#x02019;Malley et al 2012</xref>, <xref ref-type="bibr" rid="jps.REF.schwenter.2012.795">Schwenter et al 2012</xref>, <xref ref-type="bibr" rid="jps.REF.jelsig.2016.55">Jelsig et al 2016</xref>]. The findings of HHT may manifest in early childhood. A high frequency of pulmonary AVMs (and digital clubbing) and epistaxis has been consistently noted. Conversely, telangiectases do not appear to be a constant feature. Additional complications reported in individuals with JPS/HHT include anemia, migraine headaches, and exercise intolerance.</p>
          <table-wrap id="jps.T.clinical_features_of_hereditary_he" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Clinical Features of Hereditary Hemorrhagic Telangiectasia Reported in Individuals with an <italic toggle="yes">SMAD4</italic> Pathogenic Variant</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Clinical Feature</th>
                  <th id="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Individuals with this Clinical Feature</th>
                  <th id="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age of Onset</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Epistaxis</td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">61%-71%&#x000a0;<sup>1,&#x000a0;2</sup></td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">Childhood&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Telangiectases</td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">57%&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">Often after 30 years&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Mucocutaneous telangiectases</td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">48%&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">5-65 years&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Pulmonary AVM</td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">53%-81%&#x000a0;<sup>2,&#x000a0;3</sup></td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">Birth - 52 years&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Visceral AVM</td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">86%&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Hepatic AVM</td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">38%&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">21-52 years&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Intracranial AVM</td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">4%&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">22 years, range 11 years &#x000b1;7&#x000a0;<sup>1</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Aortopathy</td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">38%&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">24 years, range 21-48 years&#x000a0;<sup>5,&#x000a0;6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Intrapulmonary shunting on echocardiogram</td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">61%&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_jps.T.clinical_features_of_hereditary_he_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">5-59 years&#x000a0;<sup>3</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>HHT = hereditary hemorrhagic telangiectasia</p>
              </fn>
              <fn>
                <p>AVM = arteriovenous malformation</p>
              </fn>
              <fn id="jps.TF.2.1">
                <label>1. </label>
                <p>
                  <xref ref-type="bibr" rid="jps.REF.nishida.2012.2829">Nishida et al [2012]</xref>
                </p>
              </fn>
              <fn id="jps.TF.2.2">
                <label>2. </label>
                <p>
                  <xref ref-type="bibr" rid="jps.REF.o_malley.2012.886">O&#x02019;Malley et al [2012]</xref>
                </p>
              </fn>
              <fn id="jps.TF.2.3">
                <label>3. </label>
                <p>
                  <xref ref-type="bibr" rid="jps.REF.wain.2014.588">Wain et al [2014]</xref>
                </p>
              </fn>
              <fn id="jps.TF.2.4">
                <label>4. </label>
                <p>See <related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter">Hereditary Hemorrhagic Telangiectasia</related-object>.</p>
              </fn>
              <fn id="jps.TF.2.5">
                <label>5. </label>
                <p>
                  <xref ref-type="bibr" rid="jps.REF.heald.2015.1758">Heald et al [2015]</xref>
                </p>
              </fn>
              <fn id="jps.TF.2.6">
                <label>6. </label>
                <p>
                  <xref ref-type="bibr" rid="jps.REF.jelsig.2016.55">Jelsig et al [2016]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><xref ref-type="bibr" rid="jps.REF.wain.2014.588">Wain et al [2014]</xref> reported the frequency of HHT-related symptoms in a cohort of 34 individuals with <italic toggle="yes">SMAD4</italic> pathogenic variants (<xref ref-type="table" rid="jps.T.clinical_features_of_hereditary_he">Table 2</xref>). Intrapulmonary shunting on echocardiogram bubble study was identified in 61% of individuals. Other clinical features of HHT noted in 50% of affected individuals who did not have pulmonary or visceral AVMs included migraine headaches, exercise intolerance, and/or digital clubbing. Not all of the individuals with <italic toggle="yes">SMAD4</italic> pathogenic variants noted in these studies met the Cura&#x000e7;ao criteria for the clinical diagnosis of HHT. The Cura&#x000e7;ao criteria appear to be less sensitive for identifying individuals with <italic toggle="yes">SMAD4-</italic>related HHT [<xref ref-type="bibr" rid="jps.REF.faughnan.2011.73">Faughnan et al 2011</xref>]. The frequency with which aneurysms have been reported in <italic toggle="yes">SMAD4-</italic>related HHT is important as it suggests a more complex vascular process than classic HHT. Aneurysms may need to be considered as part of the JPS-HHT phenotype; they can affect morbidity and mortality if they are not recognized [<xref ref-type="bibr" rid="jps.REF.latchford.2012.1038">Latchford et al 2012</xref>].</p>
          <p><bold>Thoracic aortic disease</bold> (e.g., aortic root dilatation, aneurysm, and aortic dissection) and mitral valve dysfunction have been reported in individuals with <italic toggle="yes">SMAD4</italic> pathogenic variants. Some of these individuals had features overlapping with <related-object link-type="booklink" source-id="gene" document-id="taa" document-type="chapter">thoracic aortic aneurysms and aortic dissections</related-object> (TAAD) [<xref ref-type="bibr" rid="jps.REF.teekakirikul.2013.185">Teekakirikul et al 2013</xref>, <xref ref-type="bibr" rid="jps.REF.wain.2014.588">Wain et al 2014</xref>, <xref ref-type="bibr" rid="jps.REF.heald.2015.1758">Heald et al 2015</xref>]. Features overlapping with other syndromes caused by pathogenic variants in the TGF&#x003b2; pathway, such as <related-object link-type="booklink" source-id="gene" document-id="loeys-dietz" document-type="chapter">Loeys-Dietz syndrome</related-object> and <related-object link-type="booklink" source-id="gene" document-id="marfan" document-type="chapter">Marfan syndrome</related-object>, have also been reported.</p>
          <list list-type="bullet">
            <list-item>
              <p><xref ref-type="bibr" rid="jps.REF.wain.2014.588">Wain et al [2014]</xref> reported features of a connective tissue disorder in 21% (7/34) of the affected individuals in their cohort. The connective tissue features were defined as: enlarged aortic root (in 2/7), aortic and mitral insufficiency (2/7), fatal aortic dissection (1/7), retinal detachment (1/7), brain aneurysm (1/7), and lax skin and joints (1/7).</p>
            </list-item>
            <list-item>
              <p>The <italic toggle="yes">SMAD4</italic> pathogenic variants in these individuals were not confined to one region of the gene; this finding is of interest and may suggest that monitoring of the aorta to ensure timely intervention to prevent dissection would be of value [<xref ref-type="bibr" rid="jps.REF.teekakirikul.2013.185">Teekakirikul et al 2013</xref>, <xref ref-type="bibr" rid="jps.REF.wain.2014.588">Wain et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="jps.REF.heald.2015.1758">Heald et al [2015]</xref> also reported features of a connective tissue disorder in their cohort of individuals with HHT. The reported individuals did not meet clinical criteria for other known connective tissue disorders and did not have a pathogenic variant identified in other genes in the TGF&#x003b2;R2 pathway.</p>
            </list-item>
          </list>
          <p>It is clear from these studies that while features may be variable in frequency, HHT is an important medical concern for individuals with <italic toggle="yes">SMAD4</italic> pathogenic variants. Such individuals would benefit from surveillance for both the gastrointestinal and the HHT-related complications. Early data suggest that periodic monitoring of the aorta in individuals with an <italic toggle="yes">SMAD4</italic> pathogenic variant may be indicated. Surveillance in individuals with an <italic toggle="yes">SMAD4</italic> pathogenic variant may begin earlier (in keeping with HHT surveillance recommendations) than in those with a <italic toggle="yes">BMPR1A</italic> pathogenic variant (see <xref ref-type="sec" rid="jps.Surveillance">Surveillance</xref>).</p>
        </sec>
        <sec id="jps.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Genotype-phenotype correlations in general are poor; some members of families with JPS and the same pathogenic variant have a few polyps, whereas others have more than 100. The age at which polyps develop can vary from the first decade to beyond the fourth decade among affected members of the same family. Some generalizations:</p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals with JPS and an <italic toggle="yes">SMAD4</italic> pathogenic variant are more likely to have a personal or family history of upper GI polyps than individuals with pathogenic variants in <italic toggle="yes">BMPR1A</italic> or those with no known pathogenic variants. The gastric phenotype in individuals with an <italic toggle="yes">SMAD4</italic> pathogenic variant tends to be more aggressive with significant polyposis and a higher risk for gastric cancer [<xref ref-type="bibr" rid="jps.REF.aytac.2015.114">Aytac et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>Individuals with either an <italic toggle="yes">SMAD4</italic> or <italic toggle="yes">BMPR1A</italic> pathogenic variant are more likely than those without a pathogenic variant identified to have more than ten lower GI polyps and a family history of GI cancer [<xref ref-type="bibr" rid="jps.REF.burger.2002.289">Burger et al 2002</xref>, <xref ref-type="bibr" rid="jps.REF.friedl.2002.108">Friedl et al 2002</xref>, <xref ref-type="bibr" rid="jps.REF.sayed.2002.901">Sayed et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>JPS/HHT syndrome is associated with <italic toggle="yes">SMAD4</italic> pathogenic variants that are primarily within the MH2 domain (exons 8-11) [<xref ref-type="bibr" rid="jps.REF.gallione.2006.793">Gallione et al 2006</xref>, <xref ref-type="bibr" rid="jps.REF.pyatt.2006.84">Pyatt et al 2006</xref>]; however, pathogenic variants in other exons have also been observed [<xref ref-type="bibr" rid="jps.REF.gallione.2010.333">Gallione et al 2010</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="jps.Penetrance">
          <title>Penetrance</title>
          <p>One study evaluating 34 affected individuals with an <italic toggle="yes">SMAD4</italic> pathogenic variant from 20 families revealed that 31/32 (97%) developed colonic polyps (diagnosed between ages 4 and 51 years), 21/31 (68%) developed gastric polyps, and 76% had some feature of HHT [Wain et.al 2014]. In some instances, HHT-related symptoms in individuals with <italic toggle="yes">SMAD4</italic> pathogenic variants may be present prior to the onset of polyps [Author, personal observations]. Similar numbers are not available for individuals with <italic toggle="yes">BMPR1A</italic> pathogenic variants. However, <xref ref-type="bibr" rid="jps.REF.aytac.2015.114">Aytac et al [2015]</xref> reported a similar colon and small bowel phenotype among individuals with an <italic toggle="yes">SMAD4</italic> or <italic toggle="yes">BMPR1A</italic> pathogenic variant in the number and location of the polyps and surgical rates.</p>
        </sec>
        <sec id="jps.Nomenclature">
          <title>Nomenclature</title>
          <p>Terms used in the past for JPS:</p>
          <list list-type="bullet">
            <list-item>
              <p>Familial juvenile polyposis (an older term used to distinguish between simplex and familial cases; a simplex case is a single affected individual in a family)</p>
            </list-item>
            <list-item>
              <p>Generalized juvenile polyposis (to designate upper and lower GI tract involvement)</p>
            </list-item>
            <list-item>
              <p>Juvenile polyposis of infancy (a particularly severe form of the syndrome with early onset)</p>
            </list-item>
          </list>
        </sec>
        <sec id="jps.Prevalence">
          <title>Prevalence</title>
          <p>The incidence of JPS has been estimated to range between 1:16,000 and 1:100,000.</p>
        </sec>
      </sec>
      <sec id="jps.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <sec id="jps.BMPR1A">
          <title>
            <italic toggle="yes">BMPR1A</italic>
          </title>
          <p><bold>Hereditary mixed polyposis syndrome (HMPS).</bold> Germline <italic toggle="yes">BMPR1A</italic> pathogenic variants were identified in affected members of six families with features of HMPS. The polyps were reported to be of mixed adenomatous, hyperplastic, and atypical juvenile histology [<xref ref-type="bibr" rid="jps.REF.cao.2006.e13">Cao et al 2006</xref>, <xref ref-type="bibr" rid="jps.REF.cheah.2009.3027">Cheah et al 2009</xref>, <xref ref-type="bibr" rid="jps.REF.o_riordan.2010.570">O&#x02019;Riordan et al 2010</xref>] (see <xref ref-type="sec" rid="jps.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
        </sec>
        <sec id="jps.SMAD4">
          <title>
            <italic toggle="yes">SMAD4</italic>
          </title>
          <p><related-object link-type="booklink" source-id="gene" document-id="myhre" document-type="chapter"><bold>Myhre syndrome</bold></related-object> is a connective tissue disorder with multi-system involvement including cardiovascular disease, respiratory disease, gastrointestinal disease, thickened skin, proliferative fibrosis and scarring, cognitive impairment, facial dysmorphism, and short stature. To date, no cancers consistent with the typical JPS phenotype have been reported in individuals with Myhre syndrome. Myhre syndrome is caused by a heterozygous gain-of-function pathogenic variant affecting amino acid 496 or 500 in <italic toggle="yes">SMAD4.</italic></p>
        </sec>
      </sec>
      <sec id="jps.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>A juvenile polyp can result from genetic predisposition or chance. It should be noted that 1% to 2% of individuals in the general population develop a solitary juvenile polyp and do not meet diagnostic criteria for JPS.</p>
        <p>Several syndromes characterized by the presence of polyps have additional characteristics that are not associated with JPS. See <xref ref-type="table" rid="jps.T.disorders_to_consider_in_the_diffe">Table 3</xref>, <xref ref-type="table" rid="jps.T.disorders_to_consider_in_the_diffe_1">Table 4</xref>.</p>
        <table-wrap id="jps.T.disorders_to_consider_in_the_diffe" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Disorders to Consider in the Differential Diagnosis of JPS</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1">Disorder</th>
                <th id="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2">Gene(s) or Region</th>
                <th id="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_3">MOI</th>
                <th id="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Clinical Features</th>
              </tr>
              <tr>
                <th headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4" id="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Overlapping Clinical Features</th>
                <th headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4" id="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Distinguishing Clinical Features of Differential Diagnosis Disorder</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic> hamartoma tumor syndrome</related-object>
                </td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PTEN</italic>
                </td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Hamartomatous polyps</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Benign and malignant tumors of the thyroid, breast, and endometrium; macrocephaly, trichilemmomas, papillomatous papules, lipomas, pigmented macules of the glans penis</td>
              </tr>
              <tr>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="bcns" document-type="chapter">Nevoid basal cell carcinoma syndrome</related-object>
                </td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PTCH1</italic>
                  <break/>
                  <italic toggle="yes">SUFU</italic>
                </td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Gastric polyps</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Multiple jaw keratocysts, basal cell carcinoma, macrocephaly, frontal bossing, coarse facial features, facial milia</td>
              </tr>
              <tr>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="pjs" document-type="chapter">Peutz-Jeghers syndrome</related-object>
                </td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">STK11</italic>
                </td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">GI polyposis</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Mucocutaneous pigmentation, cancer predisposition; polyps have smooth muscle hyperplasia as prominent feature</td>
              </tr>
              <tr>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hereditary mixed polyposis syndrome (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/601228">601228</ext-link>)</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15q13-q14&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Juvenile polyps</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Multiple additional types of polyps: serrated, Peutz-Jeghers polyps, adenomas; significant risk of colorectal cancer</td>
              </tr>
              <tr>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Familial adenomatous polyposis (see <related-object link-type="booklink" source-id="gene" document-id="fap" document-type="chapter"><italic toggle="yes">APC</italic>-Associated Polyposis Conditions</related-object>)</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">APC</italic>
                </td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">GI polyposis</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Multiple adenomatous polyps, osteomas, dental anomalies, congenital hypertrophy of the retinal pigment epithelium, soft-tissue tumors, desmoid tumors, additional associated cancers</td>
              </tr>
              <tr>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="maps" document-type="chapter"><italic toggle="yes">MUTYH</italic>-associated polyposis</related-object>
                </td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">MUTYH</italic>
                </td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">GI polyposis</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Multiple colonic adenomatous polyps; duodenal adenomas; additional types of polyps: serrated, hyperplastic/sessile serrated, mixed; significant colorectal cancer risk; cancers of the duodenum, stomach, ovary, and bladder</td>
              </tr>
              <tr>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="hnpcc" document-type="chapter">Lynch syndrome</related-object>
                </td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">MLH1</italic>
                  <break/>
                  <italic toggle="yes">MSH2</italic>
                  <break/>
                  <italic toggle="yes">MSH6</italic>
                  <break/>
                  <italic toggle="yes">PMS2</italic>
                  <break/>
                  <italic toggle="yes">EPCAM</italic>
                </td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Colorectal polyps</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Few adenomatous polyps; significant colorectal cancer risk; cancers of the endometrium, ovary, stomach, small intestine, hepatobiliary tract, upper urinary tract, brain, and skin</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>AD = autosomal dominant</p>
            </fn>
            <fn>
              <p>GI = gastrointestinal</p>
            </fn>
            <fn id="jps.TF.3.1">
              <label>1. </label>
              <p>Duplications of 15q13-q14 lead to overexpression of <italic toggle="yes">GREM1.</italic></p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="jps.T.disorders_to_consider_in_the_diffe_1" orientation="portrait" position="anchor">
          <label>Table 4. </label>
          <caption>
            <p>Disorders to Consider in the Differential Diagnosis of JPS/HHT</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_1">Disorder</th>
                <th id="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_2">Gene(s)</th>
                <th id="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_3">MOI</th>
                <th id="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Clinical Features</th>
              </tr>
              <tr>
                <th headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_4" id="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Overlapping Clinical Features</th>
                <th headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_4" id="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Distinguishing Clinical Features of Differential Diagnosis Disorder</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter">Hereditary hemorrhagic telangiectasia</related-object><break/>(not associated with <italic toggle="yes">SMAD4</italic>)</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">ENG</italic>
                  <break/>
                  <italic toggle="yes">ACVRL1</italic>
                  <break/>
                  <italic toggle="yes">GDF2</italic>
                </td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Gastrointestinal bleeding, anemia</td>
                <td headers="hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_1_4 hd_h_jps.T.disorders_to_consider_in_the_diffe_1_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Not associated with polyposis</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>AD = autosomal dominant</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="jps.Management">
        <title>Management</title>
        <sec id="jps.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with juvenile polyposis syndrome (JPS), the following evaluations are recommended if not already completed:</p>
          <list list-type="bullet">
            <list-item>
              <p>History for abdominal pain, rectal bleeding, constipation, diarrhea, or change in stool size, shape, and/or color</p>
            </list-item>
            <list-item>
              <p>Complete blood count (CBC), colonoscopy, and upper endoscopy in the mid-teens (age 15 years) or at the time of initial symptoms, whichever is earlier</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
            <list-item>
              <p>All individuals with an <italic toggle="yes">SMAD4</italic> pathogenic variant should be evaluated for complications related to <related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter">hereditary hemorrhagic telangiectasia</related-object> (HHT)</p>
            </list-item>
          </list>
        </sec>
        <sec id="jps.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>JPS.</bold> The most effective management is routine colonoscopy with endoscopic polypectomy. Early endoscopic polypectomy may reduce morbidity by reducing the risk for cancer, bleeding, or intestinal obstruction.</p>
          <p>In some individuals, removal of all or part of the colon or stomach may be necessary to alleviate symptoms and/or reduce cancer risk when a large number of polyps are present. The preferred procedure is debated: some experts prefer subtotal colectomy with ileorectal anastomosis, whereas others prefer proctocolectomy with an ileoanal pouch. The number of colonic or rectal polyps does not appear to correlate with the need for proctectomy [<xref ref-type="bibr" rid="jps.REF.oncel.2005.49">Oncel et al 2005</xref>].</p>
          <p><bold>JPS/HHT.</bold> Treat manifestations of HHT as needed; see <related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter">Hereditary Hemorrhagic Telangiectasia</related-object>.</p>
        </sec>
        <sec id="jps.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>Increased awareness, education, and screening have helped successive generations benefit from early detection of JPS and cancer prevention/risk reduction.</p>
        </sec>
        <sec id="jps.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>When present, anemia may be improved by polypectomy or surgery.</p>
        </sec>
        <sec id="jps.Surveillance">
          <title>Surveillance</title>
          <p>For individuals with JPS who have undergone surgical resection of bowel, endoscopic follow up is required regardless of the surgical procedure because of the high rate of subsequent development of polyps in the rectum and the pouch [<xref ref-type="bibr" rid="jps.REF.oncel.2005.49">Oncel et al 2005</xref>].</p>
          <p>For individuals with an <italic toggle="yes">SMAD4</italic> or <italic toggle="yes">BMPR1A</italic> pathogenic variant identified by molecular genetic testing, individuals with a clinical diagnosis of JPS, or individuals with a family history of JPS who have not undergone molecular genetic testing or whose molecular genetic test results were uninformative [<xref ref-type="bibr" rid="jps.REF.howe.1998a.751">Howe et al 1998a</xref>] (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf">NCCN guidelines</ext-link>):</p>
          <list list-type="bullet">
            <list-item>
              <p>Monitor for rectal bleeding and/or anemia, abdominal pain, constipation, diarrhea, or change in stool size, shape, and/or color. These symptoms may warrant additional screening.</p>
            </list-item>
            <list-item>
              <p>CBC, colonoscopy, and upper endoscopy screening should begin in the mid-teens (age 15 years) or at the time of initial symptoms, whichever is earlier.</p>
              <list list-type="bullet">
                <list-item>
                  <p>If negative, screening should be repeated in three years.</p>
                </list-item>
                <list-item>
                  <p>If only one or a few polyps are identified, the polyps should be removed. Subsequently, screening should be done annually until no additional polyps are found, at which time screening every three years may resume.</p>
                </list-item>
                <list-item>
                  <p>If many polyps are identified, removal of most of the colon or stomach may be necessary. Subsequently, screening should be done annually until no additional polyps are found, at which time screening every three years may resume.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>In families in which findings suggest JPS/HHT syndrome or families with a known <italic toggle="yes">SMAD4</italic> pathogenic variant, predictive molecular genetic testing may be appropriate before age 15 years because surveillance for potential complications of HHT begins in early childhood [<xref ref-type="bibr" rid="jps.REF.gallione.2004.852">Gallione et al 2004</xref>]. Until the frequency and spectrum of HHT complications in JPS/HHT syndrome are known, it may be appropriate to follow the HHT surveillance guidelines for individuals with JPS/HHT syndrome or a known <italic toggle="yes">SMAD4</italic> pathogenic variant.</p>
          <p>Precautionary screening for individuals at risk for JPS who do not have the family-specific pathogenic variant was previously recommended [<xref ref-type="bibr" rid="jps.REF.howe.1998a.751">Howe et al 1998a</xref>]; however, this screening is unnecessary if molecular genetic testing was performed in a CLIA-approved laboratory. Family members who do not have the family-specific pathogenic variant can be screened for colon cancer as recommended for the normal U.S. population.</p>
          <p>For surveillance recommendations for individuals with HHT, see <related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter">Hereditary Hemorrhagic Telangiectasia</related-object>.</p>
        </sec>
        <sec id="jps.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate apparently asymptomatic older and younger at-risk relatives of an affected individual in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p>
          <p>In families in which findings suggest JPS or families with a known <italic toggle="yes">BMPR1A</italic> pathogenic variant, evaluations can include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Molecular genetic testing in the first to second decade of life if the pathogenic variant in the family is known;</p>
            </list-item>
            <list-item>
              <p>If the familial pathogenic variant is not known, CBC and lower intestinal endoscopy in individuals age 15 years an older. Normal results do not rule out a diagnosis of JPS (see <xref ref-type="sec" rid="jps.Surveillance">Surveillance</xref> for additional recommendations).</p>
            </list-item>
          </list>
          <p>In families in which findings suggest JPS/HHT syndrome or families with a known <italic toggle="yes">SMAD4</italic> pathogenic variant:</p>
          <list list-type="bullet">
            <list-item>
              <p>Molecular genetic testing before age 15 years for children at risk for an <italic toggle="yes">SMAD4</italic> pathogenic variant should be offered because the surveillance for HHT-related findings begins earlier in childhood than the surveillance for polyps.</p>
            </list-item>
          </list>
          <p>In families in which findings suggest JPS/HHT syndrome but the familial pathogenic variant is not known:</p>
          <list list-type="bullet">
            <list-item>
              <p>CBC and lower intestinal endoscopy in individuals age 15 years an older. Normal results do not rule out a diagnosis of JPS (see <xref ref-type="sec" rid="jps.Surveillance">Surveillance</xref> for additional recommendations).</p>
            </list-item>
            <list-item>
              <p>Individuals older than age 40 years, targeted medical history and clinical examination for features of <bold>HHT</bold>. The absence of mild but recurrent epistaxis and subtle telangiectases in characteristic locations on careful examination is reassuring (see <related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter">Hereditary Hemorrhagic Telangiectasia</related-object>).</p>
            </list-item>
            <list-item>
              <p>In individuals age 40 years and younger, targeted medical history and clinical examination for features of <bold>HHT</bold> as well as initial evaluation for brain and pulmonary AVMs, as features of <bold>HHT</bold> may not be identified by medical history and clinical examination in younger individuals.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="jps.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="jps.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>See <related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter" object-id="hht.Pregnancy_Management" object-type="sec">Hereditary Hemorrhagic Telangiectasia, Pregnancy Management</related-object></p>
        </sec>
        <sec id="jps.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="jps.Other">
          <title>Other</title>
          <p>No known chemoprevention options are effective for juvenile polyps.</p>
        </sec>
      </sec>
      <sec id="jps.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="jps.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Juvenile polyposis syndrome (JPS) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="jps.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Approximately 33% of individuals diagnosed with JPS have an affected parent.</p>
            </list-item>
            <list-item>
              <p>Most individuals diagnosed with JPS have no previous history of polyps in the family and may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of individuals with a <italic toggle="yes">de novo</italic> pathogenic variant is 67% [<xref ref-type="bibr" rid="jps.REF.calvacerqueira.2009.79">Calva-Cerqueira et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include molecular genetic testing of the parents if a pathogenic variant has been identified in the proband. If a pathogenic variant has not been identified in the proband, both parents should be screened (see <xref ref-type="sec" rid="jps.Surveillance">Surveillance</xref>) to determine if other relatives are also at risk for this condition.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>Although 75% of individuals diagnosed with JPS have an affected parent, the family history of some individuals diagnosed with JPS may appear to be negative because of failure to recognize the disorder in family members, reduced penetrance and variable expressivity, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or molecular genetic testing has been performed on the parents of the proband.</p>
            </list-item>
            <list-item>
              <p>Note: If the parent is the individual in whom the pathogenic variant first occurred, s/he may have somatic mosaicism for the variant and may be mildly/minimally affected.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected or has the pathogenic variant, the risk to the sibs is 50%. Inter- and intrafamilial variability (including variable symptoms, ages of onset, and cancer risks) has been reported among individuals with JPS.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent and/or surveillance measures have demonstrated that the parents are not likely to be affected, the risk to the sibs is negligible, as germline mosaicism has not been documented in individuals with JPS. However, parents and sibs should be aware of the symptoms associated with JPS and report them to their physician. Providers should have a low threshold for evaluating symptoms in sibs of a proband with JPS.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an affected individual with JPS has a 50% chance of inheriting the pathogenic variant and having an increased risk of developing JPS.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband&#x02019;s parents: if a parent is affected, his or her family members may be at risk and may benefit from molecular genetic testing and/or surveillance.</p>
        </sec>
        <sec id="jps.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="jps.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early surveillance and intervention.</p>
          <p><bold>Genetic cancer risk assessment and counseling.</bold> For a comprehensive description of the medical, psychosocial, and ethical ramifications of identifying at-risk individuals through cancer risk assessment with or without molecular genetic testing, see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cancer.gov/about-cancer/causes-prevention/genetics/risk-assessment-pdq">Cancer Genetics Risk Assessment and Counseling &#x02013; for health professionals</ext-link> (part of PDQ<sup>&#x000ae;</sup>, National Cancer Institute).</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>Molecular genetic testing of asymptomatic individuals younger than age 18 years.</bold> When a pathogenic variant has been identified in a family, molecular genetic testing can be used to identify family members who would benefit from early screening. Since surveillance for individuals at risk for JPS is recommended beginning at age 15 years, it is appropriate to consider presymptomatic genetic testing for JPS around this age or earlier. If parents are concerned about their child&#x02019;s ability to cope with the significance of test results, the disclosure of the molecular genetic testing information, but not surveillance, can be delayed. If symptoms of JPS appear before age 15 years, surveillance should begin at that time and disclosure of molecular genetic test results may be a reasonable option. It is important to consider the risks and benefits for children of learning this information at a young age and to consider ways to discuss this information with children and to answer their questions. Families in which there is an <italic toggle="yes">SMAD4</italic> pathogenic variant and/or associated symptoms of <related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter">hereditary hemorrhagic telangiectasia</related-object> (HHT) may wish to test in early childhood as management for HHT complications would begin in that time frame.</p>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="jps.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">SMAD4</italic> or <italic toggle="yes">BMPR1A</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for JPS are possible options.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Because most individuals with JPS will live a relatively normal life with careful screening and removal of polyps, the utility of prenatal screening appears to be outweighed by the risks. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="jps.Resources">
        <title>Resources</title>
      </sec>
      <sec id="jps.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="jps.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>How juvenile polyps form as a consequence of pathogenic variants in the germline in <italic toggle="yes">SMAD4</italic> or <italic toggle="yes">BMPR1A</italic> is not known. Although <italic toggle="yes">SMAD4</italic> is a tumor suppressor gene, loss of heterozygosity has not been demonstrated definitively as causal in the development of polyps. Furthermore, whether such changes would affect cells in the epithelium, the lamina propria, or both is also not known. <italic toggle="yes">BMPR1A</italic> is not known to be a tumor suppressor gene, although few studies have examined it in cancer.</p>
          <p><italic toggle="yes">SMAD4</italic> is the common intracellular mediator of the TGF-&#x003b2; superfamily signaling pathways. <italic toggle="yes">BMPR1A</italic> is a type I cell surface receptor for the BMP pathway. Ligands, such as TGF-&#x003b2; or BMP, bind to a receptor and activate signaling pathways leading to protein complexes that migrate to the nucleus and bind directly to DNA sequences to regulate transcription [<xref ref-type="bibr" rid="jps.REF.heldin.1997.465">Heldin et al 1997</xref>]. The downstream genes under the control of these signaling pathways are still being actively investigated.</p>
          <p>Despite the close proximity of <italic toggle="yes">BMPR1A</italic> to <italic toggle="yes">PTEN</italic> (both are on 10q22-q23), they do not appear to work together or to be members of the same pathways. A contiguous gene deletion of <italic toggle="yes">PTEN</italic> and <italic toggle="yes">BMPR1A</italic> has been associated with a severe form of early-onset JPS (previously called juvenile polyposis of infancy) [<xref ref-type="bibr" rid="jps.REF.delnatte.2006.1066">Delnatte et al 2006</xref>]. Milder phenotypes with a similar deletion of both <italic toggle="yes">PTEN</italic> and <italic toggle="yes">BMPR1A</italic> have also been reported [<xref ref-type="bibr" rid="jps.REF.salviati.2006.593">Salviati et al 2006</xref>]. The role that each gene contributes to the phenotype is unknown.</p>
          <sec id="jps.BMPR1A_1">
            <title>
              <italic toggle="yes">BMPR1A</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">BMPR1A</italic> comprises 11 coding exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="jps" object-id="jps.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Sixty pathogenic variants, including insertions, deletions, and missense, nonsense, and splice site alterations, have been described [<xref ref-type="bibr" rid="jps.REF.calvacerqueira.2009.79">Calva-Cerqueira et al 2009</xref>]. Germline deletions or pathogenic missense variants of the promoter have also been described [<xref ref-type="bibr" rid="jps.REF.calvacerqueira.2010.4654">Calva-Cerqueira et al 2010</xref>]. Large deletions of <italic toggle="yes">BMPR1A</italic> may also occur in up to 6% of individuals and be associated with additional or more severe clinical features [<xref ref-type="bibr" rid="jps.REF.aretz.2007.702">Aretz et al 2007</xref>, <xref ref-type="bibr" rid="jps.REF.van_hattem.2008.623">van Hattem et al 2008</xref>, <xref ref-type="bibr" rid="jps.REF.calvacerqueira.2009.79">Calva-Cerqueira et al 2009</xref>].</p>
            <p><bold>Normal gene product.</bold> The protein product, BMPR1A, a 533-amino acid protein encoded by 1599 nucleotides, is a type I receptor of the TGF-&#x003b2; super family that mediates the BMP intracellular signaling through <italic toggle="yes">SMAD4</italic> [<xref ref-type="bibr" rid="jps.REF.howe.2001.184">Howe et al 2001</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Abnormal BMPR1A proteins frequently result from pathogenic DNA variants in the protein kinase domain and occasionally by variants in the cysteine-rich region of the extracellular domain. No pathogenic variants have been described in the transmembrane domain [<xref ref-type="bibr" rid="jps.REF.howe.2004.484">Howe et al 2004</xref>]. In vitro studies have shown that proteins resulting from <italic toggle="yes">BMPR1A</italic> pathogenic missense variants as seen in individuals with JPS are retained in the cytoplasm and do not traffic to the cell membrane like the wild-type protein [<xref ref-type="bibr" rid="jps.REF.howe.2013.739">Howe et al 2013</xref>].</p>
          </sec>
          <sec id="jps.SMAD4_1">
            <title>
              <italic toggle="yes">SMAD4</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">SMAD4</italic> comprises 11 coding exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="jps" object-id="jps.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> See <xref ref-type="table" rid="jps.T.selected_smad4_pathogenic_allelic">Table 5</xref>. Germline pathogenic variants have been described in all eleven coding exons. Changes include small deletions, insertions, and missense and nonsense pathogenic variants. Two splice site variants have been reported. Most pathogenic variants are unique, but three have been reported in multiple unrelated families: c.1244_1247delACAG, c.1162C&#x0003e;T, and p.Arg361Cys. See <xref ref-type="bibr" rid="jps.REF.howe.2004.484">Howe et al [2004]</xref> and <xref ref-type="bibr" rid="jps.REF.calvacerqueira.2009.79">Calva-Cerqueira et al [2009]</xref> for a comprehensive list of the pathogenic variants reported in <italic toggle="yes">SMAD4</italic> (previously known as <italic toggle="yes">MADH4</italic>). Larger deletions of <italic toggle="yes">SMAD4</italic> may also occur in up to 4% of affected individuals [<xref ref-type="bibr" rid="jps.REF.aretz.2007.702">Aretz et al 2007</xref>, <xref ref-type="bibr" rid="jps.REF.van_hattem.2008.623">van Hattem et al 2008</xref>, <xref ref-type="bibr" rid="jps.REF.calvacerqueira.2009.79">Calva-Cerqueira et al 2009</xref>]. Deletions and pathogenic missense variants have also been reported in the promoter region [<xref ref-type="bibr" rid="jps.REF.calvacerqueira.2010.4654">Calva-Cerqueira et al 2010</xref>].</p>
            <table-wrap id="jps.T.selected_smad4_pathogenic_allelic" orientation="portrait" position="anchor">
              <label>Table 5. </label>
              <caption>
                <p>Selected <italic toggle="yes">SMAD4</italic> Pathogenic Allelic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_jps.T.selected_smad4_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_jps.T.selected_smad4_pathogenic_allelic_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_jps.T.selected_smad4_pathogenic_allelic_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_jps.T.selected_smad4_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1081C&#x0003e;T</td>
                    <td headers="hd_h_jps.T.selected_smad4_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg361Cys</td>
                    <td headers="hd_h_jps.T.selected_smad4_pathogenic_allelic_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucleotide&#x00026;val=NM_005359.5">NM_005359.5</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=4885457">NP_005350.1</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_jps.T.selected_smad4_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1162C&#x0003e;T</td>
                    <td headers="hd_h_jps.T.selected_smad4_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu388Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_jps.T.selected_smad4_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1244_1247delACAG</td>
                    <td headers="hd_h_jps.T.selected_smad4_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp415GlufsTer20</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The protein product, SMAD4, a 552-amino acid protein encoded by 1656 nucleotides, is a critical cytoplasmic mediator in the TGF-&#x003b2; signaling pathway.</p>
            <p><bold>Abnormal gene product.</bold> The MH1 domain of the SMAD4 protein can directly bind to the DNA of target genes. Pathogenic variants in this domain can significantly reduce the DNA binding activity of SMAD4. Most pathogenic variants, including the three recurrent pathogenic variants in <xref ref-type="table" rid="jps.T.selected_smad4_pathogenic_allelic">Table 5</xref>, occur in the MH2 domain, which plays an important role for nuclear localization, interaction with other MAD proteins, and transcriptional activation. In vitro studies demonstrate that pathogenic nonsense variants lead to significantly reduced bone morphogenetic protein signaling, with less of an effect for missense variants [<xref ref-type="bibr" rid="jps.REF.carr.2012.211">Carr et al 2012</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="jps.References">
        <title>References</title>
        <sec id="jps.Published_GuidelinesConsensus_Statem">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="jps.Published_GuidelinesConsensus_Statem.reflist0">
            <ref id="jps.REF.hampel.2015.70">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hampel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchanan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearlman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiesner</surname>
                    <given-names>GL</given-names>
                  </name>
                  <collab>Guideline Development Group, American College of Medical Genetics and Genomics Professional Practice and Guidelines Committee and National Society of Genetic Counselors Practice Guidelines Committee</collab>
                </person-group>
                <article-title>A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.</article-title>
                <source>Genet Med.</source>
                <year>2015</year>
                <volume>17</volume>
                <fpage>70</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">25394175</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF2">
              <mixed-citation publication-type="web">American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://jco.ascopubs.org/content/28/5/893.long">online</ext-link>; registration or institutional access required. 2010. Accessed 3-7-2017.</mixed-citation>
            </ref>
            <ref id="jps.REF3">
              <mixed-citation publication-type="web">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 3-7-2017.</mixed-citation>
            </ref>
            <ref id="jps.REF4">
              <mixed-citation publication-type="web">Joint Test and Technology Transfer Committee Working Group, American College of Medical Genetics. Genetic testing for colon cancer: joint statement of the American College of Medical Genetics and American Society of Human Genetics. Joint Test and Technology Transfer Committee Working Group. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111056/?tool=pubmed">online</ext-link>. 2000. Accessed 3-7-2017.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="jps.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="jps.Literature_Cited.reflist0">
            <ref id="jps.REF.aretz.2007.702">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aretz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stienen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uhlhaas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stolte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Entius</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loff</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Back</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blaas</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siebert</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holinski-Feder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sunde</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Propping</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedl</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome.</article-title>
                <source>J Med Genet</source>
                <volume>44</volume>
                <fpage>702</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17873119</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.aytac.2015.114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aytac</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sulu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heald</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Malley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaGuardia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Remzi</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalady</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Church</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Genotype-defined cancer risk in juvenile polyposis syndrome.</article-title>
                <source>Br J Surg.</source>
                <year>2015</year>
                <volume>102</volume>
                <fpage>114</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25389115</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.breckpot.2012.12">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Breckpot</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranchevent</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thienpont</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauters</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Troost</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gewillig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeesch</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreau</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devriendt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Esch</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>BMPR1A is a candidate gene for congenital heart defects associated with the recurrent 10q22q23 deletion syndrome.</article-title>
                <source>Eur J Med Genet</source>
                <volume>55</volume>
                <fpage>12</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22067610</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.brosens.2007.965">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brosens</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Hattem</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hylind</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iacobuzio-Donahue</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romans</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Axilbund</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruz-Correa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tersmette</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offerhaus</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giardiello</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Risk of colorectal cancer in juvenile polyposis.</article-title>
                <source>Gut</source>
                <volume>56</volume>
                <fpage>965</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17303595</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.burger.2002.289">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uhlhaas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mangold</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Propping</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedl</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenne</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dockter</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Back</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Novel de novo mutation of MADH4/SMAD4 in a patient with juvenile polyposis.</article-title>
                <source>Am J Med Genet</source>
                <volume>110</volume>
                <fpage>289</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">12116240</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.calvacerqueira.2009.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Calva-Cerqueira</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnathambi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pechman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bair</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsen-Haidle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>The rate of germline mutations and large deletions of SMAD4 and BMPR1A in juvenile polyposis.</article-title>
                <source>Clin Genet.</source>
                <volume>75</volume>
                <fpage>79</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">18823382</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.calvacerqueira.2010.4654">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Calva-Cerqueira</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahdaleh</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodfield</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnathambi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagy</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsen-Haidle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weigel</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Discovery of the BMPR1A promoter and germline mutations that cause juvenile polyposis.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>19</volume>
                <fpage>4654</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">20843829</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.cao.2006.e13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eu</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumarasinghe</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheah</surname>
                    <given-names>PY</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function.</article-title>
                <source>J Med Genet</source>
                <volume>43</volume>
                <fpage>e13</fpage>
                <pub-id pub-id-type="pmid">16525031</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.carr.2012.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahdaleh</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <article-title>Germline mutations in SMAD4 disrupt bone morphogenetic protein signaling.</article-title>
                <source>J Surg Res.</source>
                <year>2012</year>
                <volume>174</volume>
                <fpage>211</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">22316667</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.cheah.2009.3027">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cheah</surname>
                    <given-names>PY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chau</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koh</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eu</surname>
                    <given-names>KW</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Germline bone morphogenesis protein receptor 1A mutation causes colorectal tumorigenesis in hereditary mixed polyposis syndrome.</article-title>
                <source>Am J Gastroenterol.</source>
                <volume>104</volume>
                <fpage>3027</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">19773747</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.dahdaleh.2012.110">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dahdaleh</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calva</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <article-title>Juvenile polyposis and other intestinal polyposis syndromes with microdeletions of chromosome 10q22-23.</article-title>
                <source>Clin Genet.</source>
                <year>2012</year>
                <volume>81</volume>
                <fpage>110</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21834858</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.delnatte.2006.1066">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Delnatte</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanlaville</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mougenot</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeesch</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houdayer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blois</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genevieve</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goulet</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaubert</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romana</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoppa-Lyonnet</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes.</article-title>
                <source>Am J Hum Genet</source>
                <volume>78</volume>
                <fpage>1066</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">16685657</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.faughnan.2011.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Faughnan</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palda</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Tsao</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geisthoff</surname>
                    <given-names>UW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proctor</surname>
                    <given-names>DD</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.</article-title>
                <source>J Med Genet</source>
                <year>2011</year>
                <volume>48</volume>
                <fpage>73</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">19553198</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.friedl.2002.108">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Friedl</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uhlhaas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stolte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loff</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Back</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mangold</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stern</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knaebel</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutter</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pistorius</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Propping</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers.</article-title>
                <source>Hum Genet</source>
                <volume>111</volume>
                <fpage>108</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">12136244</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.gallione.2010.333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gallione</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aylsworth</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berk</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernhardt</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clericuzio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danesino</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drautz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahl</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faughnan</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganguly</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garvie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henderson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kini</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leedom</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lux</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maisenbacher</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzucco</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olivieri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ploos van Amstel</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prigoda-Lee</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyeritz</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reardon</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandezande</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waldman</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>RI</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchuk</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>152A</volume>
                <fpage>333</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20101697</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.gallione.2004.852">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gallione</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Repetto</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legius</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rustgi</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schelley</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tejpar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westermann</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchuk</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).</article-title>
                <source>Lancet</source>
                <volume>363</volume>
                <fpage>852</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15031030</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.gallione.2006.793">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gallione</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Letteboer</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rushlow</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prigoda</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leedom</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganguly</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castells</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ploos van Amstel</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westermann</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyeritz</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchuk</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>SMAD4 mutations found in unselected HHT patients.</article-title>
                <source>J Med Genet</source>
                <volume>43</volume>
                <fpage>793</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16613914</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.heald.2015.1758">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heald</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigelsky</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moran</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaGuardia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Malley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zahka</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence of thoracic aortopathy in patients with juvenile polyposis syndrome-hereditary hemorrhagic telangiectasia due to SMAD4.</article-title>
                <source>Am J Med Genet</source>
                <year>2015</year>
                <volume>167A</volume>
                <fpage>1758</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">25931195</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.heldin.1997.465">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heldin</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyazono</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>ten Dijke</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>TGF-beta signalling from cell membrane to nucleus through SMAD proteins.</article-title>
                <source>Nature</source>
                <volume>390</volume>
                <fpage>465</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">9393997</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.howe.2001.184">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bair</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sayed</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitros</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velculescu</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traverso</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogelstein</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.</article-title>
                <source>Nat Genet</source>
                <volume>28</volume>
                <fpage>184</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11381269</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.howe.2007.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haidle</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lal</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bair</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pechman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnathambi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>ENG mutations in MADH4.BMPR1A mutation negative patients with juvenile polyposis.</article-title>
                <source>Clin Genet</source>
                <volume>71</volume>
                <fpage>91</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">17204053</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.howe.1998a.751">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitros</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Summers</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>1998a</year>
                <article-title>The risk of gastrointestinal carcinoma in familial juvenile polyposis.</article-title>
                <source>Ann Surg Oncol</source>
                <volume>5</volume>
                <fpage>751</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9869523</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.howe.1998b.1086">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roth</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ringold</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Summers</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarvinen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistonen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlinson</surname>
                    <given-names>IP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlston</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bevan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitros</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <year>1998b</year>
                <article-title>Mutations in the SMAD4/DPC4 gene in juvenile polyposis.</article-title>
                <source>Science</source>
                <volume>280</volume>
                <fpage>1086</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9582123</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.howe.2004.484">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sayed</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ringold</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsen-Haidle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitros</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaccaro</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giardiello</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinley</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>484</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">15235019</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.howe.2013.739">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahdaleh</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherman</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>BMPR1A Mutations in Juvenile Polyposis Affect Cellular Localization.</article-title>
                <source>J Surg Res</source>
                <volume>184</volume>
                <fpage>739</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">23433720</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.jelsig.2016.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jelsig</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>T&#x000f8;rring</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kjeldsen</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qvist</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bojesen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>UB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersen</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerdes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brusgaard</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ousager</surname>
                    <given-names>LB</given-names>
                  </name>
                </person-group>
                <article-title>JP-HHT phenotype in Danish patients with SMAD4 mutations.</article-title>
                <source>Clin Genet</source>
                <year>2016</year>
                <volume>90</volume>
                <fpage>55</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">26572829</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.latchford.2012.1038">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Latchford</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neale</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>SK</given-names>
                  </name>
                </person-group>
                <article-title>Juvenile polyposis syndrome: a study of genotype, phenotype, and long-term outcome.</article-title>
                <source>Dis Colon Rectum</source>
                <year>2012</year>
                <volume>55</volume>
                <fpage>1038</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">22965402</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.nishida.2012.2829">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nishida</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faughnan</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krings</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakinala</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gossage</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pourmohamad</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henderson</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schurm</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>James</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinnine</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bharatha</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terbrugge</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>RI</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>158A</volume>
                <fpage>2829</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">22991266</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.oncel.2005.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oncel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Church</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Remzi</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fazio</surname>
                    <given-names>VW</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Colonic surgery in patients with juvenile polyposis syndrome: a case series.</article-title>
                <source>Dis Colon Rectum.</source>
                <volume>48</volume>
                <fpage>49</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">15690657</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.o_malley.2012.886">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>O&#x02019;Malley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaGuardia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalady</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parambil</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heald</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Church</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome.</article-title>
                <source>Dis Colon Rectum</source>
                <volume>55</volume>
                <fpage>886</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">22810475</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.o_riordan.2010.570">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>O&#x02019;Riordan</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Donoghue</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keegan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hawkes</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payne</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheahan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Hereditary mixed polyposis syndrome due to a BMPR1A mutation.</article-title>
                <source>Colorectal Dis.</source>
                <volume>12</volume>
                <fpage>570</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">19438883</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.pyatt.2006.84">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pyatt</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilarski</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutation screening in juvenile polyposis syndrome.</article-title>
                <source>J Mol Diagn</source>
                <volume>8</volume>
                <fpage>84</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16436638</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.salviati.2006.593">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Salviati</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patricelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guariso</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sturniolo</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alaggio</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernardi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuffardi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenconi</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Deletion of PTEN and BMPR1A on chromosome 10q23 is not always associated with juvenile polyposis of infancy.</article-title>
                <source>Am J Hum Genet</source>
                <volume>79</volume>
                <fpage>593</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16909400</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.sayed.2002.901">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sayed</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ringold</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bair</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitros</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinley</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giardiello</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogelstein</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis.</article-title>
                <source>Ann Surg Oncol</source>
                <volume>9</volume>
                <fpage>901</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12417513</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.schwenter.2012.795">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwenter</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faughnan</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gradinger</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berk</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gryfe</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollett</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durno</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation.</article-title>
                <source>J Gastroenterol</source>
                <volume>47</volume>
                <fpage>795</fpage>
                <lpage>804</lpage>
                <pub-id pub-id-type="pmid">22331366</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.sweet.2005.2465">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sweet</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>XP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallione</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alhopuro</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khoo</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patocs</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bridgeman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilarski</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehtonen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frebourg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teh</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchuk</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis.</article-title>
                <source>JAMA</source>
                <volume>294</volume>
                <fpage>2465</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">16287957</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.teekakirikul.2013.185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Teekakirikul</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milewicz</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacro</surname>
                    <given-names>RV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Regalado</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosales</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryan</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toler</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations.</article-title>
                <source>Am J Med Genet A</source>
                <volume>161A</volume>
                <fpage>185</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">23239472</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.van_hattem.2008.623">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Hattem</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brosens</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Leng</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morsink</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lens</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carvalho</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giardiello</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offerhaus</surname>
                    <given-names>GJ</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis.</article-title>
                <source>Gut.</source>
                <volume>57</volume>
                <fpage>623</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18178612</pub-id>
              </element-citation>
            </ref>
            <ref id="jps.REF.wain.2014.588">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wain</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellingson</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gammon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pichurin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winship</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riegert-Johnson</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weitzel</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                </person-group>
                <article-title>Appreciating the broad clinical features of SMAD4 mutation carriers: a multicenter chart review.</article-title>
                <source>Genet Med.</source>
                <year>2014</year>
                <volume>16</volume>
                <fpage>588</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">24525918</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="jps.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="jps.Suggested_Reading.reflist0">
            <ref id="jps.REF.howe">
              <mixed-citation publication-type="book">Howe JR. Juvenile polyposis syndrome. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID)</italic>. Chap 35. New York, NY: McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="jps.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="jps.Author_Notes">
          <title>Author Notes</title>
          <p>Dr. Howe is a surgical oncologist and primary researcher in the field of juvenile polyposis syndrome. Joy Larsen Haidle is a genetic counselor with the Cancer Genetics program at North Memorial Medical Center who is actively involved in the development of genetic counseling guidelines with Dr. Howe&#x02019;s research program.</p>
        </sec>
        <sec id="jps.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>9 March 2017 (sw) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>3 December 2015 (jrh) Revision: corrections to <xref ref-type="sec" rid="jps.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</xref></p>
            </list-item>
            <list-item>
              <p>22 May 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>29 September 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>9 September 2008 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>22 February 2007 (cd) Revision: prenatal diagnosis available for <italic toggle="yes">BMPR1A</italic> mutations</p>
            </list-item>
            <list-item>
              <p>2 November 2006 (cd) Revision: prenatal diagnosis available for <italic toggle="yes">SMAD4</italic> mutations</p>
            </list-item>
            <list-item>
              <p>13 June 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>20 May 2004 (cd) Revision: Genetic Counseling</p>
            </list-item>
            <list-item>
              <p>27 October 2003 (cd) Revision: Statements and Policies</p>
            </list-item>
            <list-item>
              <p>13 May 2003 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>4 January 2003 (jrh) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
